These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 27149033)

  • 1. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.
    Samuel M; Healey JS; Nault I; Sterns LD; Essebag V; Gray C; Hruczkowski T; Gardner M; Parkash R; Sapp JL
    JACC Clin Electrophysiol; 2023 Jun; 9(6):808-821. PubMed ID: 37380314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.
    Coyle K; Coyle D; Nault I; Parkash R; Healey JS; Gray CJ; Gardner MJ; Sterns LD; Essebag V; Hruczkowski T; Blier L; Wells GA; Tang ASL; Stevenson WG; Sapp JL
    JACC Clin Electrophysiol; 2018 May; 4(5):660-668. PubMed ID: 29798795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.
    Deyell MW; Steinberg C; Doucette S; Parkash R; Nault I; Gray C; Essebag V; Gardner M; Sterns LD; Healey JS; Hruczkowski T; Rivard L; Leong-Sit P; Nery PB; Sapp JL
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):603-608. PubMed ID: 29356207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial.
    Sapp JL; Tang ASL; Parkash R; Stevenson WG; Healey JS; Wells G
    Am Heart J; 2024 Aug; 274():1-10. PubMed ID: 38649085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
    Deyell MW; Doucette S; Parkash R; Nault I; Gula L; Gray C; Gardner M; Sterns LD; Healey JS; Essebag V; Sapp JL
    Europace; 2022 Jul; 24(7):1112-1118. PubMed ID: 35030257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
    Di Biase L; Romero J; Du X; Mohanty S; Trivedi C; Della Rocca DG; Patel K; Sanchez J; Yang R; Alviz I; Mohanty P; Gianni C; Tarantino N; Zhang XD; Horton R; Al-Ahmad A; Lakkireddy D; Burkhardt DJ; Chen M; Natale A
    Heart Rhythm; 2021 Jun; 18(6):885-893. PubMed ID: 33592323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic catheter ablation for the prevention of defibrillator therapy.
    Reddy VY; Reynolds MR; Neuzil P; Richardson AW; Taborsky M; Jongnarangsin K; Kralovec S; Sediva L; Ruskin JN; Josephson ME
    N Engl J Med; 2007 Dec; 357(26):2657-65. PubMed ID: 18160685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH.
    Gula LJ; Doucette S; Leong-Sit P; Tang ASL; Parkash R; Sarrazin JF; Thibault B; Essebag V; Tung SK; Deyell MW; Raymond JM; Lane C; Nery PB; Veenhuyzen GD; Redfearn DP; Healey JS; Roux JF; Giddens K; Sapp JL
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):421-434. PubMed ID: 29316012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
    Žižek D; Mrak M; Jan M; Zupan Mežnar A; Ivanovski M; Žlahtič T; Kajdič N; Antolič B; Klemen L; Skale R; Avramovič Gregorič J; Štublar J; Pernat A; Šinkovec M
    Europace; 2024 May; 26(5):. PubMed ID: 38657209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.